CLINICAL TRIAL ASSESSMENT

Detailed analysis of Phase 1-4 clinical trial design, endpoints chosen (or lack thereof), populations, inclusion/exclusion criteria and timelines. We can combine methodologies to understand trial processes, plans, and monitor recruitment.